Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 9, 2012, Pages 1823-1829

  Senzolo, M ^a   Rodriguez Castro, K I ^a   Rossetto, V ^a   Radu, C ^a   Gavasso, S ^a   Carraro, P ^a   Zerbinati, P ^a   Sartori, M T ^a   Simioni, P ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anti Xa; Anticoagulation; Antithrombin; Cirrhosis; Low molecular weight heparin

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ADULT; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IN VITRO STUDY; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; THROMBIN TIME; THROMBOGENESIS; THROMBOSIS; TREATMENT RESPONSE;

ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84865709973     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04824.x     Document Type: Article

References (15)

1. Lisman T, Leebeek FW, De Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37: 280-7.
2. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-8.
3. Aldawood A, Arabi Y, Aljumah A, Alsaadi A, Rishu A, Aldorzi H, Alqahtani S, Alsultan M, Felemban A. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J 2011; 9: 1.
4. Bechmann LP, Sichau M, Wichert M, Gerken G, Kroger K, Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 2011; 31: 75-82.
5. Lisman T, Porte RJ. Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int 2011; 31: 1063.
6. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Büller HR, Prins MH. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999; 94: 3702-6.
7. Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, Wouter ten Cate J, Girolami A, Prins MH. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
8. Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR. X-linked thrombophilia with a mutant factor IX (factor IX Padua). N Engl J Med 2009; 361: 1671-5.
9. Simioni P, Kalafatis M, Tormene D, Luni S, Zerbinati P, Barzon L, Palù G, Girolami A. Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide)). Thromb Haemost 2001; 86: 1017-22.
10. Tormene D, Fortuna S, Tognin G, Gavasso S, Pagnan A, Prandoni P, Simioni P. The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study. J Thromb Haemost 2005; 3: 1414-20.
11. Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred. Clin Appl Thromb Hemost 2000; 6: 36-40.
12. Tormene D, De Stefano V, Grandone E, Za T, Perlati M, Rossi E, Margaglione M, Simioni P. The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study. J Thromb Haemost 2007; 5: 2193-6.
13. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-40.
14. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
15. Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 2003; 88: 547-54.